Haplosufficiency of the melanocortin-4 receptor gene in individuals with deletions of 18q

被引:25
作者
Cody, JD
Reveles, XT
Hale, DE
Lehman, D
Coon, H
Leach, RJ
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78284 USA
[2] Univ Texas, Hlth Sci Ctr, Dept Pediat, San Antonio, TX 78284 USA
[3] Univ Utah, Sch Med, Dept Psychiat, Salt Lake City, UT 84112 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1007/s004390051125
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The melanocortin-4, receptor (MC4R) is a seven, transmembrane G-protein-coupled receptor whose ligand, alpha-melanocyte-stimulating hormone (alpha-MSH), is a posttranslational derivative of pro-opiomelanocortin (POMC). The regulatory pathway, of which MC4R is a part, has become an area of intense interest because of its potential role in obesity. Three studies have identified individuals with dominantly inherited obesity segregating with mutations in the MC4R gene. It has been hypothesized that the mutation found in these subjects resulted in a loss of gene function resulting in obesity due to haploinsufficiency of the MC4R gene. We have been studying the molecular basis of the phenotype of individuals with large deletions of chromosome 18q. Due to its location at 18q21.3, the MC4R gene is hemizygous in approximately one-third of the individuals in our study. If hemizygosity of the MC4R gene results in haploinsufficiency-induced obesity, then individuals with deletions of 18q whose deletions include the MC4R gene should be obese in comparison with those individuals whose deletion does not include the gene. Our data indicate no difference in obesity among those deleted and not deleted for the gene. This supports the hypothesis that the MC4R gene product is haplosufficient and the involvement of MC4R in obesity may reflect a dominant negative effect.
引用
收藏
页码:424 / 427
页数:4
相关论文
共 14 条
  • [1] Cody JD, 1997, AM J MED GENET, V69, P280, DOI 10.1002/(SICI)1096-8628(19970331)69:3<280::AID-AJMG12>3.0.CO
  • [2] 2-N
  • [3] Cohen J., 1988, STAT POWER ANAL BEHA, DOI 10.1016/C2013-0-10517-X
  • [4] Gay CT, 1997, AM J MED GENET, V74, P422, DOI 10.1002/(SICI)1096-8628(19970725)74:4<422::AID-AJMG14>3.0.CO
  • [5] 2-K
  • [6] HALL JG, 1989, HDB NORMAL PHYSICAL
  • [7] Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans
    Hinney, A
    Schmidt, A
    Nottebom, K
    Heibült, O
    Becker, I
    Ziegler, A
    Gerber, G
    Sina, M
    Görg, T
    Mayer, H
    Siegfried, W
    Fichter, M
    Remschmidt, H
    Hebebrand, J
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (04) : 1483 - 1486
  • [8] Targeted disruption of the melanocortin-4 receptor results in obesity in mice
    Huszar, D
    Lynch, CA
    FairchildHuntress, V
    Dunmore, JH
    Fang, Q
    Berkemeier, LR
    Gu, W
    Kesterson, RA
    Boston, BA
    Cone, RD
    Smith, FJ
    Campfield, LA
    Burn, P
    Lee, F
    [J]. CELL, 1997, 88 (01) : 131 - 141
  • [9] Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene
    Jackson, RS
    Creemers, JWM
    Ohagi, S
    RaffinSanson, ML
    Sanders, L
    Montague, CT
    Hutton, JC
    ORahilly, S
    [J]. NATURE GENETICS, 1997, 16 (03) : 303 - 306
  • [10] Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans
    Krude, H
    Biebermann, H
    Luck, W
    Horn, R
    Brabant, G
    Grüters, A
    [J]. NATURE GENETICS, 1998, 19 (02) : 155 - 157